Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents

ClinicalTrials.gov ID: NCT00097071

Public ClinicalTrials.gov record NCT00097071. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 10:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety and Efficacy of Insulin Aspart Versus Insulin Lispro in Insulin Pumps in Children and Adolescents With Type 1 Diabetes

Study identification

NCT ID
NCT00097071
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
299 participants

Conditions and interventions

Interventions

  • insulin aspart Drug
  • insulin lispro Drug

Drug

Eligibility (public fields only)

Age range
3 Years to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2004
Primary completion
Apr 30, 2006
Completion
Apr 30, 2006
Last update posted
Dec 21, 2016

2004 – 2006

United States locations

U.S. sites
52
U.S. states
32
U.S. cities
47
Facility City State ZIP Site status
Novo Nordisk Investigational Site Mobile Alabama 36617
Novo Nordisk Investigational Site Montgomery Alabama 36106
Novo Nordisk Investigational Site Phoenix Arizona 85016
Novo Nordisk Investigational Site Little Rock Arkansas 72202
Novo Nordisk Investigational Site Loma Linda California 92354
Novo Nordisk Investigational Site Sacramento California 95816
Novo Nordisk Investigational Site San Diego California 92123
Novo Nordisk Investigational Site Denver Colorado 80262
Novo Nordisk Investigational Site Englewood Colorado 80110
Novo Nordisk Investigational Site New Haven Connecticut 06520
Novo Nordisk Investigational Site Orlando Florida 32806-1101
Novo Nordisk Investigational Site St. Petersburg Florida 33701
Novo Nordisk Investigational Site Tallahassee Florida 32308
Novo Nordisk Investigational Site Atlanta Georgia 30318
Novo Nordisk Investigational Site Idaho Falls Idaho 83404-7596
Novo Nordisk Investigational Site Indianapolis Indiana 46202-2879
Novo Nordisk Investigational Site Iowa City Iowa 52242
Novo Nordisk Investigational Site Topeka Kansas 66606
Novo Nordisk Investigational Site Wichita Kansas 67226
Novo Nordisk Investigational Site Baton Rouge Louisiana 70808
Novo Nordisk Investigational Site Baltimore Maryland 21229
Novo Nordisk Investigational Site Baltimore Maryland 21287
Novo Nordisk Investigational Site Boston Massachusetts 02115
Novo Nordisk Investigational Site Boston Massachusetts 02215
Novo Nordisk Investigational Site Springfield Massachusetts 01107
Novo Nordisk Investigational Site Worcester Massachusetts 01655
Novo Nordisk Investigational Site Detroit Michigan 48202-2689
Novo Nordisk Investigational Site Minneapolis Minnesota 55416
Novo Nordisk Investigational Site Minneapolis Minnesota 55455
Novo Nordisk Investigational Site Kansas City Missouri 64108
Novo Nordisk Investigational Site Omaha Nebraska 68114
Novo Nordisk Investigational Site Omaha Nebraska 68198-3020
Novo Nordisk Investigational Site Hackensack New Jersey 07601
Novo Nordisk Investigational Site Brooklyn New York 11219
Novo Nordisk Investigational Site Buffalo New York 14222
Novo Nordisk Investigational Site Manhasset New York 11030
Novo Nordisk Investigational Site The Bronx New York 10467
Novo Nordisk Investigational Site Asheville North Carolina 28803
Novo Nordisk Investigational Site Chapel Hill North Carolina 27599-7220
Novo Nordisk Investigational Site Columbus Ohio 43203
Novo Nordisk Investigational Site Tulsa Oklahoma 74136
Novo Nordisk Investigational Site Portland Oregon 97239
Novo Nordisk Investigational Site Hershey Pennsylvania 17033
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19107
Novo Nordisk Investigational Site Pittsburgh Pennsylvania 15224
Novo Nordisk Investigational Site Charleston South Carolina 29425
Novo Nordisk Investigational Site San Antonio Texas 78229
Novo Nordisk Investigational Site San Antonio Texas 78284
Novo Nordisk Investigational Site Norfolk Virginia 23507
Novo Nordisk Investigational Site Seattle Washington 98105
Novo Nordisk Investigational Site Charleston West Virginia 25302
Novo Nordisk Investigational Site Milwaukee Wisconsin 53226-0509

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00097071, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 21, 2016 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00097071 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →